iProgen Biotech Inc.

iProgen offers proprietary, modular platforms that enhances both the antibody delivery to tumor cells and antibody-receptor internalization. The platform unlocks numerous receptors that were previously overlooked or not considered for ADC development.

Address

Visit website (opens in a new tab)
Loading